Summary Chemical structures of the sugar chains of various human ax-fetoprotein (AFP) species with different affinity for Concanavalin A (Con A) and Lens culinaris agglutinin (LCA) were examined by pyridylamination of their oligosaccharides and stepwise exoglycosidase digestion. Using reversed-phase and size-fractionation high performance liquid chromatography systems we identified six pyridylamino-sugar chains. The Con A-reactive and LCA-nonreactive species of AFP from patients with hepatocellular carcinoma contained a biantennary sugar chain, and the Con A-reactive and LCA-reactive species had a biantennary one with a fucose residue at the innermost N-acetylglucosamine residue. The Con A-nonreactive and LCA-reactive species contained a biantennary sugar chain both with a bisecting-N-acetylglucosamine residue at the trimannosyl core and with a focuse residue at the innermost N-acetylglucosamine residue. The Con A-nonreactive and LCA-nonreactive species contained a fucosylated triantennary sugar chain as a major component, and two minor components: a triantennary sugar chain and a biantennary sugar chain with a bisecting-N-acetylglucosamine residue at the trimannosyl core. Thus, the fucosylated and non-fucosylated triantennary sugar chains were newly identified in human AFP. Essentially identical results were obtained for AFP from the patient with gallbladder carcinoma which metastasises to the liver. These results indicate that the increment in fucosylation and branching to form new antennae is a characteristic feature of the carbohydrate chains of AFP from patients with neoplastic diseases of the liver.
The measurement of the serum concentration of a-fetoprotein (AFP) has been used extensively for the early diagnosis of hepatocellular carcinoma (HCC) during a follow-up process of chronic liver diseases (Abelev, 1986; O'Conor et al., 1970; Nishi & Hirai, 1973) . However, the serum concentration of AFP also increases in patients with carcinomas of digestive organs which metastasise to the liver (Alpert et al., 1971; Mcintire et al., 1975) and with nonneoplastic diseases of the liver (Karvountzis & Redeker, 1974; Alpert & Feller, 1978) .
Several investigators and we have reported that the reactivity of AFP with Lens culinaris agglutinin (LCA) and concanavalin A (Con A) is a good measure for distinction between HCC, nonneoplastic diseases of the liver and carcinomas of digestive organs which metastasise to the liver (Ruoslahti et al., 1978; Breborowicz et al., 1981; Ishiguro et al., 1985; Taketa & Hirai, 1989; Aoyagi et al., 1984 Aoyagi et al., , 1991 . The molecular basis for the different affinity of AFP for LCA and Con A is presumed to be the difference in fucosylation at the innermost N-acetylglucosamine residue and bisectingCorrespondence: Y. Aoyagi. In this paper, the terms of sugar chains are used for those with structures as follows. Biantennary, Galp1-4GlcNAcp1-2 (Galpl-4Glc NAcp1-2 Manal-3) Manp1-4 GlcNAcp1-4 GlcNAc-PA; agalactobiantennary, GlcNAcp1-2 Manml-6) GlcNAcpl-2 Mana 1-3) Manp1-4 GlcNAc,1-4 GlcNAc-PA; trimannosyl, Manpl-4 GlcNAcp1-4 GlcNAc-PA; fucosylated biantennary, Galpl-4 GlcNAcpl-2 Manal-6 (Galp1-4 GlcNAcp1-2 Manal-3) Manpl-4 GlcNAcpl-4 (Fucal-6) GlcNAc-PA; fucosylated and N-acetylglucosaminylated biantennary, Galp1-4 GlcNAcp1-2 Manal-6 (GlcNAcp1-4) (Galpl-4 GlcNAcpI-2 Manal-3) NAcp1-4 (Fuca1-6) GIcNAc-PA; N-acetylglucosaminylated biantennary, Galp1-4 GlcNAcpl-2 Manal-6 (GlcNAcpl-4) GlcNAcp1-2 Manal-3) Manpl-4 GlcNAcpl-4 GlcNAc-PA; fucosylated triantennary, Galp1-4 GlcNAcpl-4 (Galp1-4 GlcNAcp1-2) Manal-3 (Galp1-4 GlcNAcp1-2 GlcNAc-PA; triantennary, Galp1-4 GlcNAcp1-4 (Galp1-4 GlcNAcp1-2) (Galipl-4 GIcNAcp1-2 Manxl-6) Manpl-4 GIcNAcpI-4 GlcNAc-PA; agalactotriantennary, GlcNAcp1-4 (Glc NAcp1-2) GlcNAc-PA. Received 5 June 1992; and in revised form 8 October 1992. glucosaminylation in the biantennary carbohydrate chain (Aoyagi et al., 1985) . However, precise chemical structures of sugar chains in these molecular species of AFP have not been fully determined.
In this manuscript, we report the chemical structures of sugar chains of human AFP molecular species with special reference to reactivity to lectins and the disease category.
Materials and methods
Materials AFP specimens were prepared from serum samples of two patients with HCC and a patient with gallbladder carcinoma which metastasises to the liver by affinity chromatography as described previously (Aoyagi et al., 1977) . Con A-and LCASepharose 4B beads were obtained from Pharmacia Fine Chemicals, Uppsala, Sweden. Lyophilised Con A and LCA, bovine epididymal a-L-fucosidase, Jack beans P-N-acetylglucosaminidase, and neuraminidase from Clostridium perfringens, type X, were from Sigma Chemical Co., St. Louis, MO, USA. P-Galactosidase from E. coli was purchased from Boehringer Mannheim, Germany. Authentic pyridylamino (PA)-oligosaccharide standards were from Takara Shuzo Co., Ltd. Kyoto, Japan, and their structures were verified by 'H-nuclear magnetic resonance by the manufacturer. Anhydrous hydrazine was from Pierce Chemical Company, Rockford, Ill, USA and 2-aminopyridine was from Nacalai Tesque, Kyoto, Japan. Sodium cyanoborohydride was from Aldrich Chem. Co., Milw., WI, USA. The other reagents were of analytical grade.
Methods
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis The purity of the AFP prepared by affinity chromatography was checked by sodium dodecyl sulfate-polyacrylamide gel electrophoresis according to the method of Laemmli (1970) .
Isolation of AFP species with different affinity for Con A and LCA Four AFP species, i.e., Con A-nonreactive and LCAnonreactive (Con A(-)/LCA(-)), Con A-nonreactive and LCA-reactive (Con A(-)/LCA( + )), Con A-reactive and LCA-nonreactive (Con A(+)/LCA(-)), Con A-reactive and LCA-reactive (Con A( + )/LCA( + )} species were obtained from each AFP sample with Con A-and LCA-Sepharose 4B as described previously (Aoyagi et al., 1985) .
Crossed immunoaffinoelectrophoresis Purity of each molecular species of AFP with different affinity for Con A and LCA was examined by crossed immunoaffinoelectrophoresis as described previously (Aoyagi et al., 1984) .
Preparation of PA-sugar chains Sugar chains of AFP samples were released by hydrazinolysis at 100°C for 10 h and free amino groups were N-acetylated.
Then, the free oligosaccharides were reductively aminated with a fluorescent reagent, 2-aminopyridine, by use of sodium cyanoborohydride, and PA-derivatives of each oligosaccharide preparation were fractionated by Sephadex G-15 gel filtration (1 x 50 cm) according to the method described previously (Hase et al., 1984; Yamamoto et al., 1989) . Each of these four AFP species (30-100 nmoles) different in lectin affinity was subjected to hydrazinolysis to prepare PA-oligosaccharides, and subsequently PA-sugar chains from each species (50-300 pmoles) were applied to HPLC analysis. The yields of hydrazinolysis and reductive amination with 2-aminopyridine were 60-70 and 85-90%, respectively. Thus, overall yield was around 60%.
Carbohydrate structure of Con A ( + )/LCA (-) species of AFP
The PA-oligosaccharide of the Con A( + )/LCA(-) species of AFP from HCC patient 1 was eluated at the position of the authentic PA-biantennary chain', both on reversed-phase HPLC ( Figure 2 ) and on size-fractionation HPLC. by ,-galactosidase and subsequent P-N-acetylglucosaminidase digestion, the elution positions were converted to that of the PAagalactobiantennary chain, and that of the PA-trimannosyl sugar chain, respectively (results not shown). Essentially identical elution profiles of HPLC were obtained with the PAoligosaccharide of the Con A(+)/LCA(-) species of AFP from HCC patient 2 and the patient with gallbladder carcinoma which metastasises to the liver (results not shown).
Carbohydrate structure of Con A(+)/LCA(+) species of AFP The PA-oligosaccharide of the Con A( + )/LCA( +) species of AFP from HCC patient 1 was eluted at the position of the authentic PA-fucosylated biantennary chain, both on reversed-phase HPLC ( Figure 3a ) and on size-fractionation HPLC (Figure 4a ). Upon digestion with fucosidase, the elution position was converted to that of the authentic PA-biantennary chain, as shown in Figure 3c Carbohydrate structure of Con A (-)/LCA (-) species of AFP Figure 6a shows an elution profile of the PA-oligosaccharides of the Con A(-)/LCA(-) species of AFP from HCC patient 1 on size-fractionation HPLC. The major peak (peak 1 in Figure 6a ), representing 40 and 45% of the total peak areas in patient 1 and patient 2, respectively, was eluted at the position of the authentic PA-fucosylated triantennary chain (peak 4 in Figure 6c ). The PA-triantennary oligosaccharide (peak 3 in Figure 6c ) was also detected as a minor component (representing 14 and 22% of the total peak areas in the respective patient, peak 2 in Figure 5a ). Upon fucosidase digestion, the major peak disappears, and an increase of the peak at the position of the authentic PA-triantennary chain, was observed (peak 2 in Figure 6b ). To confirm the chemical structure of the sugar chain, the main peak oligosaccharide was collected, and a portion was subjected to fucosidase digstion. Figure 7a shows an elution profile of the PA-oligosaccharide thus isolated on sizefractionation HPLC. The elution position (peak 1 in Figure  7a ) was same as that of the PA-fucosylated triantennary chain (peak 6 in Figure 7c ). Fucosidase digestion gave an oligosaccharide eluted at a position (peak 2 in Figure 7b ) of the authentic PA-triantennary chain (peak 5 in Figure 7c ). the fucosidase-treated oligosaccharide was collected and then subjected to P-galactosidase digestion and subsequently to P-N-acetylglucosaminidase digestion. The elution positions of resultant oligosaccharides (peak 3 in Figure 7d and peak 4 in Figure 7e ) were identical with those of authentic oligosaccharides, a PA-agalactotriantennary chain (peak 2 in Figure   7f ), and a PA-trimannosyl chain (peak 1 in Figure 7f ) standards, respectively.
The elution profile of the PA-oligosaccharide of the Con A(-)/LCA(-) species of AFP from HCC patient 1 by reversed-phase HPLC is shown in Figure 8 . By this reversedphase HPLC with Cosmosil 5C18-P, the PA-oligosaccharide of the N-acetylglucosaminylated biantennary chain and that of the fucosylated triantennary chain were eluted at almost the same position (peak 4 in Figure 8c and peak 5 in Figure  8d ), and therefore it was difficult to know their presence or absence. However, when digested with fucosidase, a major peak (2 in Figure 8b ) was shifted to the position of the PA-triantennary chain (peak 3 in Figure 8c) . A minor peak (1 in Figure 8b ) remaining at the initial position after repeated fucosidase digestions was considered to represent Nacetylglucosaminylated biantennary chain (peak 5 in Figure  8d ). These results indicated that major components of PAoligosaccharides of Con A(-)/LCA(-) species of AFP from the patient with HCC was the fucosylated triantennary chain. Although it was difficult to identify each peak, several minor components eluted at faster positions than that of the major fucosidase-digested PA-oligosaccharides of the Con A(-)/ LCA(-) species of AFP of patient 1. The major peak (I in a, 40% of the total peak area) was eluted at the position of the fucosylated triantennary chain (4 in c). The PA-triantennary chain was also detected as a minor component (2 in a, 14% of the total peak area). By fucosidase digestion, the main peak at the elution position of the PA-fucosylated triantennary chain disappeared, and an increase of a peak (2 in b) at the position of PA-triantennary chain was observed. Authentic PA-oligosaccharide standards in c are: 1, biantennary chain; 2, fucosylated biantennary chain; 3, triantennary chain; and 4, fucosylated trianternnary chain. Elution time (min) Figure 7 Size-fractionation HPLC elution profiles of the isolated PA-oligosaccharide (peak I in Figure Sa ) and its stepwise exoglycosidase digest. The elution position of the native one (1 in a) was same as that of the fucosylated triantennary chain (6 in c), and a-fucosidase digestion gave a peak (2 in b) corresponding to the triantennary chain (5 in b). The oligosaccharide of this peak was collected and subjected to P-galactosidase digestion and subsequently to P-N-actylglucosaminidase digestion. The P-galactosidase digest gave a peak (3 in d) corresponding to the agalactotriantennary chain (2 in f), and P-N-acetyl-glucosaminidase digest gave a peak (4 in e) at the position of the trimannosyl chain (1 in f). Authentic PA-oligosaccharide standards in c and f are: 1, trimannosyl chain; 2, agalactotriantennary chain; 3, biantennary chain; 4, fucosylated biantennary chain; 5, triantennary chain; and 6, fucosylated triantennary chain.
component (Figure 6a ), apepared to be fucosylated species, because after fucosidase digestion these minor peaks disappeared and new peaks became detectable at faster position than that of untreated minor components (Figure 6b ). Essentially the same elution profiles on HPLC were obtained for Con A(-)/LCA(-) species of AFP from HCC patient 2 and the patient with gallbladder carcinoma which metastasises to the liver. However, the ratio (10.1) of the fucosylated to non-fucosylated triantennary sugar chains of AFP from the patient with gallbladder carcinoma which metastasises to the liver was much higher than those (3.2 for patient 1 and 1.9 for patient 2) in patients with HCC. The peak areas due to the fucosylated and the nonfucosylated triantennary chains in this disease represented 32 and 3% of the total area, respectively.
Discussion
It is now accepted that there are several molecular species of AFP with different affinity for Con A and LCA. LCA binds specifically the biantennary chain with a fucose residue at the innermost N-acetylglucosamine residue at the trimannosyl core (fucosylated biantennary chain) and that both with a fucose and a bistecting-N-acetylglucosamine residue (fucosylated and N-acetylglucosaminylated biantennary chain) (Kornfeld et al., 1981) . However, if these biantennary structures undergo modification of further branching leading to triantennary structures, they become nonreactive with LCA (Montreuil et al., 1983) . On the other hand, Con A binds specifically the biantennary and the fucosylated biantennary chains. This binding does not occur if the biantennary sugar chain structure undergoes modification of bisecting-glucosaminylation and/or further branching leading to the formation of the triantennary and tetraantennary structures (Baenziger & Fiete, 1979) .
On the basis of these facts, we have proposed the carbohydrate structures of various AFP species with difference in affinity for Con A and LCA (Aoyagi et al., 1985 (Aoyagi et al., , 1991 Kornfeld et al., 1981; Montreuil et al., 1983; Baenziger et al., 1979 ), but they remain to be confirmed.
Recently, a very sensitive and convenient method has been developed to study the fine carbohydrate structures by combination of derivatisation into fluorescent oligosaccharide and separation by HPLC (Hase et al., 1984; Tomiya et al., 1988; Yamamoto et al., 1989; Nishiura et al., 1990) . Since a number of PA-oligosaccharide, the structures of which have been established by 'H-nuclear magnetic resonance, have become commercially available, we applied this method to study the fine structures of various AFP species.
The present results are summarised in Table II . Here, we propose the classification of carbohydrate structures of human AFP according to the reactivity with lectins and the disease category (Table II) . The first is the Con A( + )/ LCA(-) sugar chain, and the structure is of the biantennary complex type, a basic carbohydrate structure of AFP. This structure is predominantly observed in AFP of nonneoplastic liver diseases. The second is the Con A(+)/LCA(+) chain composed of the fucosylated biantennary complex type, which is predominantly observed in AFP of HCC. The third is the Con A(-)/LCA(+) chain which is the biantennary complex type with fucosylation and bisecting-N-acetylglucosaminylation, and this type is observed predominantly in AFP of carcinomas of digestive organs which metastasise to the liver and yolk sac tumour. The fourth is the Con A(-)/ LCA(-) chain which includes three kinds of carbohydrate structure, namely, the biantennary complex type with bisecting-acetylglucosaminylation, the triantennary complex type and the triantennary complex type with fucosylation. The N-acetyl-glucosaminylated biantennary chain is predominantly observed in AFP of carcinoma which metastasises to the liver and yolk sac tumour. The triantennary chain and its fucosylated form are present in AFP of HCC, carcinoma which metastasises to the liver and yolk sac tumour.
Recently we reported that the measurement of a fucosylation index of AFP is useful for distinction between HCC and nonneoplastic diseases of the liver (Aoyagi et al., 1984 (Aoyagi et al., , 1991 . The fucosylation index of AFP was defined as the percentage of the LCA-reactive species in total AFP (Aoyagi et al., 1991) . The present study revealed that more than the 40% of Con A-nonreactive species of AFP were fucosylated, even if it is not reactive with LCA. In our previous study the percentage of the Con A-nonreactive species of AFP was 5 ± 7% in 351 patients with HCC (Aoyagi et al., 1991) On the other hand, they reported that human AFP did not contain the triantennary chain. However, our present study clearly indicated the presence of the triantennary chains with and without a fucose residue at the innermost N-acetylglucosamine residue in AFP from patients with neoplastic diseases of the liver. Thus, this is the first report to establish the presence of these structures in detail in human AFP. In the case of AFP of foetal calf serum, Krusius and Ruoslahti (1982) found the same structure at the triantennary chain reported here. Bayard et al. (1983) showed that the presence in rat AFP of a similar species to our N-acetylglucosaminylated biantennary chain. Although the precise molecular basis for these variations is not clear at present, it is conceivable to assume that the difference in a set of sugar transferases expressed would lead to the qualitative and quantitative differences in each molecular species of AFP. This study was supported in part by a Grant-in-Aid from The Niigata University Science Foundation.
